跳至主要内容
临床试验/NCT01571310
NCT01571310已完成不适用

Effect of Breakfast Omission on Postprandial Glycemia After Lunch and Dinner in T2D

Tel Aviv University3 个研究点 分布在 2 个国家目标入组 30 人开始时间: 2012年7月最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
30
试验地点
3
主要终点
Postprandial Glucose Response

研究概览

简要总结

The investigators will explore the effect of omission of breakfast on postprandial hyperglycemia and insulin and intact GLP-1 response after subsequent meals in type 2 diabetic patients

详细描述

In obesity and in type 2 diabetes eating behavior especially the lack of breakfast promote weight gain, increase hunger and carbohydrate craving.

The present study is designed to address whether in T2D, a change in meal timing; specifically, by adding calories, protein and carbohydrates to the breakfast vs.the omission of breakfast will influence the postprandial elevation of glucose, insulin, intact GLP-1, glucagon and free fatty acids (FFA) after subsequent meals at lunch and dinner.

The investigators expect that compared to the day with breakfast condition the day when the breakfast will be omitted the postprandial glucose , free fattly acids, and glucagon response after lunch and dinner will be significative higher while insulin and intact GLP-1 response after lunch and dinner will be reduced

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
30 Years 至 70 Years(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Type 2 diabetics for < 10yr
  • HbA1C: 7-9 %
  • BMI: 22 to 35 kg/m2)
  • Age: ≥30 and ≤70 years of age
  • Habitually eat breakfast
  • Naïve or treated with oral antidiabetic drugs and those with anti-hypertensive and lipid-lowering medication
  • Those treated with insulin or GLP-1 analogs or having major liver, heart or kidney illnesses will be excluded.
  • Usually wake up between 06:00 and 07:00 and go to sleep between 22:00 and 24:
  • Not dieting and no change in body weight >10 lb = 4.5 kg within the last 6 months
  • Stable physical activity pattern during the three months immediately preceding study initiation
  • Normal liver and kidney function 12 No metabolic disease other then diabetes
  • Usually wakes up between 05:00 and 07:00 and goes to sleep between 22:00 and 24:
  • Normal TSH and FT4 levels
  • Acceptable health based on interview, medical history, physical examination, and laboratory tests
  • Those who provide signed informed consent

排除标准

  • Type 1 diabetes
  • Pulmonary disease, psychiatric, immunological, neoplastic diseases or severe diabetic complications, such as cardiovascular disease, cerebrovascular disease, proliferative diabetic retinopathy, gastroparesis or underwent bariatric surgery.
  • Abnormal liver function tests defined as an increase by a factor of at least 2 above the upper normal limit of alanine aminotransferase and/or aspartate
  • Anemia (Hg > 10g/dL)
  • Serum creatinine level > 1.5 mg/dl
  • Pregnant or lactating
  • Participating in another dietary program or use of weight-loss medications
  • Documented or suspected history (within one year) of illicit drug abuse or alcoholism.
  • Use of psychotropic or anoretic medication during the month immediately prior to study onset
  • 13.Work shifts within the last 5 years and did not cross time zones within the last month of the study.

研究组 & 干预措施

Omitted Breakfast

Experimental

Experimental: The patients in Omitted Breakfast day will omit the breakfast and will continue the fast until noon. Thereafter will eat Lunch at 13;30 and Dinner at 19:00

干预措施: Omitted Breakfast (Other)

Omitted Breakfast

Experimental

Experimental: The patients in Omitted Breakfast day will omit the breakfast and will continue the fast until noon. Thereafter will eat Lunch at 13;30 and Dinner at 19:00

干预措施: Breakfast (Other)

Breakfast

Active Comparator

The patients in Breakfast day will consume breakfast at 8:00 and then lunch at 13;30 and dinner at 19:00

干预措施: Omitted Breakfast (Other)

Breakfast

Active Comparator

The patients in Breakfast day will consume breakfast at 8:00 and then lunch at 13;30 and dinner at 19:00

干预措施: Breakfast (Other)

结局指标

主要结局

Postprandial Glucose Response

时间窗: 12 weeks

Postprandial Glucose response will be measure after lunch and dinner

次要结局

  • Postprandial Insulin Response(12 weeks)
  • Postprandial intact-GLP-1 Response(12 weeks)
  • Postprandial Glucagon Response(12 weeks)
  • Postprandial Free Fatty Acids Response(12 weeks)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Daniela Jakubowicz

Prof. Daniela Jakubowicz MD

Tel Aviv University

研究点 (3)

Loading locations...

相似试验